Resurrecting DNAzymes as sequence-specific therapeutics

Science Translational Medicine

Volumn 4, Issue 139, 2012, Pages

  Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; DEOXYRIBOZYME; MESSENGER RNA; PROTEIN C JUN;

ANTIGEN EXPRESSION; BASE PAIRING; BIOCATALYSIS; CANCER INHIBITION; CONCENTRATION (PARAMETERS); DNA DETERMINATION; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CODE; HUMAN; MOLECULAR MODEL; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE MOTIF; PRIORITY JOURNAL; RNA CLEAVAGE; SEQUENCE ANALYSIS; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; ANIMAL; GENETICS; NOTE; SKIN TUMOR;

ANIMALS; DNA, CATALYTIC; HUMANS; PROTO-ONCOGENE PROTEINS C-JUN; SKIN NEOPLASMS;

EID: 84862893498     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3004080     Document Type: Short Survey

References (10)

1. C. Guerrier-Takada, K. Gardiner, T. Marsh, N. Pace, S. Altman, The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857 (1983).
2. A. J. Zaug, T. R. Cech, The intervening sequence RNA of Tetrahymena is an enzyme. Science 231, 470-475 (1986).
3. J. Haseloff, W. L. Gerlach, Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585-591 (1988).
4. H. Cai, F. S. Santiago, L. Prado-Lourenco, B. Wang, M. Patrikakis, M. P. Davenport, G. J. Maghzal, R. Stocker, C. R. Parish, B. H. Chong, G. J. Lieschke, T.-W. Wong, C. N. Chesterman, D. J. Francis, F. J. Moloney, R. St.C. Barnetson, G. M. Halliday, L. M. Khachigian, DNAzyme targeting c-jun suppresses skin cancer growth. Sci. Transl. Med. 139, 139ra82 (2012).
5. S. W. Santoro, G. F. Joyce, A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. U.S.A. 94, 4262-4266 (1997).
6. C. R. Dass, P. F. Choong, L. M. Khachigian, DNAzyme technology and cancer therapy: Cleave and let die. Mol. Cancer Ther. 7, 243-251 (2008).
7. M. L. Tan, P. F. M. Choong, C. R. Dass, DNAzyme delivery systems: Getting past first base. Expert Opin. Drug Deliv. 6, 127-138 (2009).
8. T. L. Jason, J. Koropatnick, R. W. Berg, Toxicology of antisense therapeutics. Toxicol. Appl. Pharmacol. 201, 66-83 (2004).
9. A. Judge, I. MacLachlan, Overcoming the innate immune response to small interfering RNA. Hum. Gene Ther. 19, 111-124 (2008).
10. M. E. Kleinman, K. Yamada, A. Takeda, V. Chandrasekaran, M. Nozaki, J. Z. Baffi, R. J. Albuquerque, S. Yamasaki, M. Itaya, Y. Pan, B. Appukuttan, D. Gibbs, Z. Yang, K. Karikó, B. K. Ambati, T. A. Wilgus, L. A. DiPietro, E. Sakurai, K. Zhang, J. R. Smith, E. W. Taylor, J. Ambati, Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452, 591-597 (2008).